Benzinga's Top #PreMarket Losers
March 18, 2015 at 08:14 AM EDT
Nektar Therapeutics (NASDAQ: NKTR) shares fell 16.50% to $11.80 in pre-market trading after the company said its breast cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.